The peripheral blood and bone marrow NK [CD16+] cells of pediatric patients with ALL, as well as those of healthy controls, differentially expressed the 10 TLRs, as shown in Figures 3, –5, which show the representative results of one patient from each of the studied groups. The gene discussed is FCGR3A; the disease is acute lymphoblastic leukemia.